Genelux Ownership 2024 | Who Owns Genelux Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

17.85%

Institutional Holders

21.00

Genelux Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	-	-	14,501	14,501	100.00%	402,257,000	Mar 31, 2023
BARCLAYS PLC	-	0.00%	33,178	33,178	100.00%	920,000	Mar 31, 2023
MORGAN STANLEY	-	-	1,984	1,984	100.00%	55,036,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	0.00%	10,615	10,615	100.00%	294,460,000	Mar 31, 2023
UBS GROUP AG	-	-	184	184	100.00%	5,104,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	0.00%	1,001	1,001	100.00%	27,768,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	2,000	2,000	100.00%	55,000,000	Mar 31, 2023
JPMORGAN CHASE & CO	-	-	100	100	100.00%	3,000,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,018	1,018	100.00%	28,239,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	-	-	162	162	100.00%	4,494,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	0.00%	15,176	15,176	100.00%	420,982,000	Mar 31, 2023
NORTHERN TRUST CORP	-	0.00%	11,185	11,185	100.00%	310,272,000	Mar 31, 2023
CITIGROUP INC	-	0.00%	3,031	3,031	100.00%	84,080,000	Mar 31, 2023
STATE STREET CORP	-	-	7,700	7,700	100.00%	213,598,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	0.00%	8,647	8,647	100.00%	239,868,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	0.00%	1,147	1,147	100.00%	32,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	0.00%	37,709	37,709	100.00%	1,046,047,000	Mar 31, 2023
VANGUARD GROUP INC	-	-	67,658	67,658	100.00%	1,876,832,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	0.00%	8,763	8,763	100.00%	243,000	Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC	-	0.36%	44,940	44,940	100.00%	1,246,636,000	Mar 31, 2023

Genelux's largest institutional shareholder is BLACKROCK INC., holding 0.00% of the company's total share outstanding, currently valued at $402.26M. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HOHIMER WEALTH MANAGEMENT, LLC	-	0.36%	44,940	44,940	100.00%	1,246,636,000	Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC	-	0.04%	16,668	16,668	100.00%	462,370,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	0.00%	1,147	1,147	100.00%	32,000	Mar 31, 2023
BARCLAYS PLC	-	0.00%	33,178	33,178	100.00%	920,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	0.00%	8,763	8,763	100.00%	243,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	0.00%	37,709	37,709	100.00%	1,046,047,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	0.00%	15,176	15,176	100.00%	420,982,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	0.00%	10,615	10,615	100.00%	294,460,000	Mar 31, 2023
NORTHERN TRUST CORP	-	0.00%	11,185	11,185	100.00%	310,272,000	Mar 31, 2023
CITIGROUP INC	-	0.00%	3,031	3,031	100.00%	84,080,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	0.00%	1,001	1,001	100.00%	27,768,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	0.00%	8,647	8,647	100.00%	239,868,000	Mar 31, 2023
VANGUARD GROUP INC	-	-	67,658	67,658	100.00%	1,876,832,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	-	-	162	162	100.00%	4,494,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	2,000	2,000	100.00%	55,000,000	Mar 31, 2023
STATE STREET CORP	-	-	7,700	7,700	100.00%	213,598,000	Mar 31, 2023
BLACKROCK INC.	-	-	14,501	14,501	100.00%	402,257,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,018	1,018	100.00%	28,239,000	Mar 31, 2023
MORGAN STANLEY	-	-	1,984	1,984	100.00%	55,036,000	Mar 31, 2023
UBS GROUP AG	-	-	184	184	100.00%	5,104,000	Mar 31, 2023

The largest Genelux shareholder by % of total assets is HOHIMER WEALTH MANAGEMENT, LLC. The company owns 44.94K shares of Genelux (GNLX), representing 0.36% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	-	-	67,658	67,658	100.00%	1,876,832,000	Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC	-	0.36%	44,940	44,940	100.00%	1,246,636,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	0.00%	37,709	37,709	100.00%	1,046,047,000	Mar 31, 2023
BARCLAYS PLC	-	0.00%	33,178	33,178	100.00%	920,000	Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC	-	0.04%	16,668	16,668	100.00%	462,370,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	0.00%	15,176	15,176	100.00%	420,982,000	Mar 31, 2023
BLACKROCK INC.	-	-	14,501	14,501	100.00%	402,257,000	Mar 31, 2023
NORTHERN TRUST CORP	-	0.00%	11,185	11,185	100.00%	310,272,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	0.00%	10,615	10,615	100.00%	294,460,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	0.00%	8,763	8,763	100.00%	243,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	0.00%	8,647	8,647	100.00%	239,868,000	Mar 31, 2023
STATE STREET CORP	-	-	7,700	7,700	100.00%	213,598,000	Mar 31, 2023
CITIGROUP INC	-	0.00%	3,031	3,031	100.00%	84,080,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	2,000	2,000	100.00%	55,000,000	Mar 31, 2023
MORGAN STANLEY	-	-	1,984	1,984	100.00%	55,036,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	0.00%	1,147	1,147	100.00%	32,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,018	1,018	100.00%	28,239,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	0.00%	1,001	1,001	100.00%	27,768,000	Mar 31, 2023
UBS GROUP AG	-	-	184	184	100.00%	5,104,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	-	-	162	162	100.00%	4,494,000	Mar 31, 2023

As of Mar 31 2023, Genelux's largest institutional buyer is VANGUARD GROUP INC. The company purchased 67.66K stocks of GNLX, valued at $1.88B.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	100	100	100.00%	3,000,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	-	-	162	162	100.00%	4,494,000	Mar 31, 2023
UBS GROUP AG	-	-	184	184	100.00%	5,104,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	0.00%	1,001	1,001	100.00%	27,768,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,018	1,018	100.00%	28,239,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	0.00%	1,147	1,147	100.00%	32,000	Mar 31, 2023
MORGAN STANLEY	-	-	1,984	1,984	100.00%	55,036,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	2,000	2,000	100.00%	55,000,000	Mar 31, 2023
CITIGROUP INC	-	0.00%	3,031	3,031	100.00%	84,080,000	Mar 31, 2023
STATE STREET CORP	-	-	7,700	7,700	100.00%	213,598,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	0.00%	8,647	8,647	100.00%	239,868,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	0.00%	8,763	8,763	100.00%	243,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	0.00%	10,615	10,615	100.00%	294,460,000	Mar 31, 2023
NORTHERN TRUST CORP	-	0.00%	11,185	11,185	100.00%	310,272,000	Mar 31, 2023
BLACKROCK INC.	-	-	14,501	14,501	100.00%	402,257,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	0.00%	15,176	15,176	100.00%	420,982,000	Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC	-	0.04%	16,668	16,668	100.00%	462,370,000	Mar 31, 2023
BARCLAYS PLC	-	0.00%	33,178	33,178	100.00%	920,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	0.00%	37,709	37,709	100.00%	1,046,047,000	Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC	-	0.36%	44,940	44,940	100.00%	1,246,636,000	Mar 31, 2023

As of Mar 31 2023, Genelux's biggest institutional seller is JPMORGAN CHASE & CO. The company sold 100.00 shares of GNLX, valued at $3.00M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	-	-	67,658	67,658	100.00%	1,876,832,000	Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC	-	0.36%	44,940	44,940	100.00%	1,246,636,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	0.00%	37,709	37,709	100.00%	1,046,047,000	Mar 31, 2023
BARCLAYS PLC	-	0.00%	33,178	33,178	100.00%	920,000	Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC	-	0.04%	16,668	16,668	100.00%	462,370,000	Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	0.00%	15,176	15,176	100.00%	420,982,000	Mar 31, 2023
BLACKROCK INC.	-	-	14,501	14,501	100.00%	402,257,000	Mar 31, 2023
NORTHERN TRUST CORP	-	0.00%	11,185	11,185	100.00%	310,272,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	0.00%	10,615	10,615	100.00%	294,460,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	0.00%	8,763	8,763	100.00%	243,000	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	0.00%	8,647	8,647	100.00%	239,868,000	Mar 31, 2023
STATE STREET CORP	-	-	7,700	7,700	100.00%	213,598,000	Mar 31, 2023
CITIGROUP INC	-	0.00%	3,031	3,031	100.00%	84,080,000	Mar 31, 2023
ROYAL BANK OF CANADA	-	-	2,000	2,000	100.00%	55,000,000	Mar 31, 2023
MORGAN STANLEY	-	-	1,984	1,984	100.00%	55,036,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	0.00%	1,147	1,147	100.00%	32,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	1,018	1,018	100.00%	28,239,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	0.00%	1,001	1,001	100.00%	27,768,000	Mar 31, 2023
UBS GROUP AG	-	-	184	184	100.00%	5,104,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	-	-	162	162	100.00%	4,494,000	Mar 31, 2023
JPMORGAN CHASE & CO	-	-	100	100	100.00%	3,000,000	Mar 31, 2023

Genelux's largest new institutional shareholder by number of shares is VANGUARD GROUP INC, purchased 67.66K shares, valued at $1.88B, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Genelux Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.03%	13,500	-	-	Mar 31, 2024
Humankind Benefit Corp	0.02%	447	205	84.71%	Dec 31, 2023
SCHWAB CAPITAL TRUST	0.00%	51,982	-	-	Jan 31, 2024
ETF Series Solutions	0.00%	7,294	1,168	19.07%	Feb 29, 2024
PUTNAM ASSET ALLOCATION FUNDS	0.00%	10,341	-	-	Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	6,408	-1,115	-14.82%	Mar 31, 2024
Global X Funds	0.00%	8,772	-	-	Jan 31, 2024
CLEARWATER INVESTMENT TRUST	0.00%	851	851	-	Mar 28, 2024
NORTHERN FUNDS	0.00%	10,496	-973	-8.48%	Mar 28, 2024
RYDEX SERIES FUNDS	0.00%	169	-	-	Dec 31, 2023
Goldman Sachs ETF Trust	0.00%	3,925	-	-	Feb 29, 2024
RYDEX DYNAMIC FUNDS	0.00%	84	-	-	Dec 31, 2023
PENN SERIES FUNDS INC	0.00%	600	-	-	Mar 28, 2024
SEASONS SERIES TRUST	0.00%	470	-	-	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	2,161	9	0.42%	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,601	731	39.09%	Jan 31, 2024
RYDEX VARIABLE TRUST	0.00%	11	-	-	Dec 31, 2023
TIAA-CREF FUNDS	0.00%	25,224	6,659	35.87%	Jan 31, 2024
Brighthouse Funds Trust II	0.00%	6,436	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	2,102	-9	-0.43%	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	7,378	-	-	Mar 31, 2024
Advisors' Inner Circle Fund III	0.00%	62	62	-	Jan 31, 2024
BLACKROCK FUNDS	0.00%	2,964	-	-	Jan 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	2,223	-225	-9.19%	Jan 31, 2024
iSHARES TRUST	0.00%	5,492	-726,364	-99.25%	Mar 31, 2024

Genelux's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 13.50K shares, compromising 0.03% of its total assets.

Genelux Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	21	-

As of 31 Mar 23, 21 institutions are holding Genelux's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	287,367	-

Genelux (GNLX) has 287.37K shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	-	-

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	-	-

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	21	-	287,367	-	-	-	-	-	-	-

Genelux Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jul 08, 2024	Yu Yong	officer	VP, Clinical Trial Operations	S-Sale	Sell	6,849	$2.12	$14.52K	10,869

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jul 08, 2024	Yu Yong	officer	VP, Clinical Trial Operations	S-Sale	Sell	6,849	$2.12	$14.52K	10,869

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 05, 2024	Tyree James L	director	-	A-Award	Buy	50,469	$1.54	$77.72K	50,469
Aug 05, 2024	Tyree James L	director	-	A-Award	Buy	39,541	-	-	49,251
Aug 05, 2024	Mirabelli Mary	director	-	A-Award	Buy	39,541	-	-	52,001
Aug 05, 2024	Mirabelli Mary	director	-	A-Award	Buy	50,469	$1.54	$77.72K	50,469
Aug 05, 2024	Thomas John	director	-	A-Award	Buy	39,541	-	-	505,501
Aug 05, 2024	Thomas John	director	-	A-Award	Buy	50,469	$1.54	$77.72K	50,469
Aug 05, 2024	Smither John W	director	-	A-Award	Buy	39,541	-	-	52,711
Aug 05, 2024	Smither John W	director	-	A-Award	Buy	50,469	$1.54	$77.72K	50,469
Jul 08, 2024	Zindrick Thomas	director, officer	President and CEO	A-Award	Buy	26,264	-	-	50,207
Jul 08, 2024	Zindrick Thomas	director, officer	President and CEO	A-Award	Buy	8,320	-	-	22,971
Jul 08, 2024	Zak Lourie S.	officer	Chief Financial Officer	A-Award	Buy	3,852	-	-	38,428
Jul 08, 2024	Zak Lourie S.	officer	Chief Financial Officer	A-Award	Buy	1,220	-	-	32,470
Jul 08, 2024	Smalling Ralph	officer	Head of Regulatory	A-Award	Buy	2,107	-	-	18,144
Jul 08, 2024	Smalling Ralph	officer	Head of Regulatory	A-Award	Buy	616	-	-	13,931
Jul 08, 2024	Cappello Joseph	officer	VP, Pharmaceutical Development	A-Award	Buy	11,557	-	-	20,953
Jul 08, 2024	Cappello Joseph	officer	VP, Pharmaceutical Development	A-Award	Buy	3,661	-	-	9,396
Jul 08, 2024	Yu Yong	officer	VP, Clinical Trial Operations	A-Award	Buy	11,557	-	-	17,718
Jul 08, 2024	Yu Yong	officer	VP, Clinical Trial Operations	S-Sale	Sell	6,849	$2.12	$14.52K	10,869
Jul 08, 2024	Yu Yong	officer	VP, Clinical Trial Operations	A-Award	Buy	3,661	-	-	6,161
Jul 08, 2024	Ryder Sean	officer	General Counsel	A-Award	Buy	9,270	-	-	22,778

The last insider sell of Genelux's stock was made by Yu Yong on Jul 08 2024, selling 6,849 shares at $2.12 per share (valued at $14.52K).

Genelux Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	13	-
Q4 2023	3	22	13.64%
Q3 2023	22	55	40.00%
Q2 2023	-	2	-
Q1 2023	17	17	100.00%

0 total buy trades, and 13 total sell trades (buy/sell ratio of 0.00%) were made by Genelux's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	13	-
Q4 2023	-	20	-
Q3 2023	-	50	-
Q2 2023	-	-	-
Q1 2023	1	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 13 open market sell trades of Genelux's stocks.

Genelux Peer Ownership

Ticker	Company
DYAI	Dyadic International, Inc.
CGEM	Cullinan Oncology, Inc.
MNPR	Monopar Therapeutics Inc.
IVA	Inventiva S.A.
CNTA	Centessa Pharmaceuticals plc
IKNA	Ikena Oncology, Inc.
LRMR	Larimar Therapeutics, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
CING	Cingulate Inc.
TERN	Terns Pharmaceuticals, Inc.
MLTX	MoonLake Immunotherapeutics
GLUE	Monte Rosa Therapeutics, Inc.
ABOS	Acumen Pharmaceuticals, Inc.
NAMS	NewAmsterdam Pharma Company N.V.
IMRX	Immuneering Corporation
CELC	Celcuity Inc.
CMPX	Compass Therapeutics, Inc.
AMLX	Amylyx Pharmaceuticals, Inc.

GNLX Ownership FAQ

Who Owns Genelux?

Genelux is owned by institutional shareholders (0%), insiders (17.85%), and public (0%). The largest institutional shareholder of Genelux is BLACKROCK INC. (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.03% of total shares).

Who are the major institutional shareholders of Genelux?

Genelux's major institutional shareholders are BLACKROCK INC., BARCLAYS PLC, MORGAN STANLEY, CITADEL ADVISORS LLC, and UBS GROUP AG. The top five shareholders own together 0% of the company's share outstanding.

How many Genelux shareholders are there?

As of Mar 2023, there are 21 institutional shareholders of Genelux.

What percentage of Genelux is owned by BLACKROCK INC?

BLACKROCK INC owns 14.5K shares of Genelux, representing 0% of the company's total shares outstanding, valued at $402.26M (as of Mar 2023).

What percentage of Genelux is owned by BARCLAYS PLC?

As of Mar 2023, BARCLAYS PLC holds 33.18K shares of Genelux (GNLX), compromising 0% of the company, valued at $920K.

What percentage of Genelux is owned by MORGAN STANLEY?

MORGAN STANLEY is the third largest holder of Genelux. The company owns 1.98K of the company's shares outstanding (worth $55.04M).